documents: FDA-2022-N-2390-0028

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-N-2390-0028 FDA FDA-2022-N-2390 Letter from McDermott Will & Emery on behalf of Vanda Pharmaceuticals, Inc to FDA CDER Other Letter(s) 2023-09-19T04:00:00Z 2023 9 2023-09-19T04:00:00Z   2023-09-19T18:30:32Z   0 0 0900006485fd20d7

Links from other tables